Skip to content

Multicenter, randomized controlled trial of electroacupuncture for chronic radicular pain due to lumbar disc herniation

Multicenter, randomized controlled trial of electroacupuncture for chronic radicular pain due to lumbar disc herniation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001425
Enrollment
Unknown
Registered
2026-06-05
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic radicular pain due to lumbar disc herniation

Interventions

Sham Electroacupuncture Group:Sham electroacupuncture (Sham EA) Point selection: Non-meridian, non-acupoint points located 2 cm lateral to the acupuncture points used in the verum EA group. Needling

Sponsors

Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria (1) Meet the diagnostic criteria for chronic radicular pain due to lumbar disc herniation as described above; (2) History of radicular lower limb pain lasting = 12 weeks; (3) Aged 18 to 65 years, male or female; (4) Low back and leg pain Visual Analogue Scale (VAS) score = 40 mm; (5) Provide informed consent, sign the informed consent form, and voluntarily participate in this study. Note: Patients must meet all five criteria listed above to be enrolled in this study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria (1) Radicular pain caused by other definite etiologies other than lumbar disc herniation, such as lumbar spinal stenosis, spinal tumor, infection, metabolic disease, fracture, ankylosing spondylitis, rheumatoid arthritis, etc., as confirmed by MRI or CT; (2) Spinal deformity (spondylolisthesis, spondylolysis, or scoliosis) or sequestered/migrated lumbar disc herniation; (3) Extraspinal diseases (e.g., vascular or genitourinary disorders); (4) Suspected or existing progressive neurological deficit (e.g., progressive muscle weakness) or cauda equina syndrome (requiring emergency surgery); (5) Low back pain accompanied by pain in two or more other body regions; (6) Use of a pacemaker, or presence of bleeding disorders or severe coagulation dysfunction; (7) Prior history of lumbar or lumbar disc surgery; (8) History of needle phobia (syncope upon needling); (9) Previous receipt of electroacupuncture treatment, or receipt of acupuncture treatment for the same diagnosis within the past year; (10) Current use of glucocorticoids, non-steroidal anti-inflammatory drugs (NSAIDs), or other medications with therapeutic effects on radicular pain; (11) Severe cardiac disease, epilepsy, hepatic or renal insufficiency, hematopoietic system disorders, or other serious concomitant diseases (e.g., cancer); (12) Severe mental or psychological disorders, cognitive dysfunction, or other conditions that preclude cooperation with treatment and evaluation; (13) Planned spinal surgery or other interventional procedures (e.g., epidural steroid injection) during the trial treatment period; (14) Pregnancy, lactation, or planned pregnancy; (15) Any other condition that, in the opinion of the investigator, makes the patient unsuitable for participation in this clinical trial. Note: Patients meeting any one of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS) for Low Back Pain;Visual Analogue Scale (VAS) for leg pain;

Secondary

MeasureTime frame
Oswestry Disability Index Score (ODI);Japanese Orthopaedic Association (JOA) Lumbar Function Score;36-Item Short Form Health Survey Score (SF-36);Fear-Avoidance Beliefs Questionnaire()ABQ);Patient Global Assessment (PGA);Rescue Medication Use;Incidence of adverse events (AEs);Patient Blinding Assessment (PBA);

Countries

China

Contacts

Public ContactYi Guo

Tianjin University of Traditional Chinese Medicine

guoyi_168@163.com13920921016

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 29, 2026